<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">MBio</journal-id><journal-id journal-id-type="hwp">mbio</journal-id><journal-id journal-id-type="pmc">mbio</journal-id><journal-id journal-id-type="publisher-id">mBio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29789365</article-id><article-id pub-id-type="pmc">5964358</article-id><article-id pub-id-type="publisher-id">mBio02392-17</article-id><article-id pub-id-type="doi">10.1128/mBio.02392-17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial</article-title><alt-title alt-title-type="running-head">Microbiota Effects on Hyperglycemia and Hyperlipidemia</alt-title><alt-title alt-title-type="short-authors">Tong et al.</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Tong</surname><given-names>Xiaolin</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xu</surname><given-names>Jia</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lian</surname><given-names>Fengmei</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Yu</surname><given-names>Xiaotong</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Zhao</surname><given-names>Yufeng</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Xu</surname><given-names>Lipeng</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Zhang</surname><given-names>Menghui</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Zhao</surname><given-names>Xiyan</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Shen</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Wu</surname><given-names>Shengping</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Pang</surname><given-names>Xiaoyan</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Tian</surname><given-names>Jiaxing</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Zhang</surname><given-names>Chenhong</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Zhou</surname><given-names>Qiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Wang</surname><given-names>Linhua</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Pang</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Chen</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Peng</surname><given-names>Zhiping</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Wang</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Zhen</surname><given-names>Zhong</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Fang</surname><given-names>Chao</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Li</surname><given-names>Min</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" equal-contrib="no"><name><surname>Chen</surname><given-names>Limei</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="no"><name><surname>Zhao</surname><given-names>Liping</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><aff id="aff1"><label>a</label><addr-line>Guang&#x02019;anmen Hospital, China Academy of Chinese Medical Sciences, Beijing</addr-line>, People&#x02019;s Republic of China</aff><aff id="aff2"><label>b</label><addr-line>State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People&#x02019;s Republic of China</addr-line></aff><aff id="aff3"><label>c</label><addr-line>Graduate School, Beijing University of Chinese Medicine, Beijing, People&#x02019;s Republic of China</addr-line></aff><aff id="aff4"><label>d</label><addr-line>Shanghai Centre for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, People&#x02019;s Republic of China</addr-line></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Bik</surname><given-names>Elisabeth M.</given-names></name><role>Invited Editor</role><aff>uBiome</aff></contrib><contrib contrib-type="editor"><name><surname>Blaser</surname><given-names>Martin J.</given-names></name><role>Editor</role><aff>New York University</aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Xiaolin Tong, <email>xiaolintong66@sina.com</email>, or Liping Zhao, <email>lpzhao@sjtu.edu.cn</email>.</corresp><fn fn-type="equal"><p>X.T., J.X., and F.L. contributed equally to this article.</p></fn><fn fn-type="other"><p>This article is a direct contribution from a Fellow of the American Academy of Microbiology. Solicited external reviewers: Jun Wang, Institute of Microbiology, Chinese Academy of Sciences; Xinhua Xiao, Peking Union Medical College Hospital.</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><season>May-Jun</season><year>2018</year></pub-date><volume>9</volume><issue>3</issue><elocation-id>e02392-17</elocation-id><history><date date-type="received"><day>22</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>1</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mbo003183901001.pdf"/><abstract><title>ABSTRACT</title><p>Accumulating evidence implicates gut microbiota as promising targets for the treatment of type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis that alteration of gut microbiota may be involved in the alleviation of T2DM with hyperlipidemia by metformin and a specifically designed herbal formula (AMC). Four hundred fifty patients with T2DM and hyperlipidemia were randomly assigned to either the metformin- or AMC-treated group. After 12&#x000a0;weeks of treatment, 100 patients were randomly selected from each group and assessed for clinical improvement. The effects of the two drugs on the intestinal microbiota were evaluated by analyzing the V3 and V4 regions of the 16S rRNA gene by Illumina sequencing and multivariate statistical methods. Both metformin and AMC significantly alleviated hyperglycemia and hyperlipidemia and shifted gut microbiota structure in diabetic patients. They significantly increased a coabundant group represented by <italic>Blautia</italic> spp., which significantly correlated with the improvements in glucose and lipid homeostasis. However, AMC showed better efficacies in improving homeostasis model assessment of insulin resistance (HOMA-IR) and plasma triglyceride and also exerted a larger effect on gut microbiota. Furthermore, only AMC increased the coabundant group represented by <italic>Faecalibacterium</italic> spp., which was previously reported to be associated with the alleviation of T2DM in a randomized clinical trial. Metformin and the Chinese herbal formula may ameliorate type 2 diabetes with hyperlipidemia via enriching beneficial bacteria, such as <italic>Blautia</italic> and <italic>Faecalibacterium</italic> spp.</p></abstract><abstract abstract-type="executive-summary"><title>IMPORTANCE</title><p>Metabolic diseases such as T2DM and obesity have become a worldwide public health threat. Accumulating evidence indicates that gut microbiota can causatively arouse metabolic diseases, and thus the gut microbiota serves as a promising target for disease control. In this study, we evaluated the role of gut microbiota during improvements in hyperglycemia and hyperlipidemia by two drugs: metformin and a specifically designed Chinese herbal formula (AMC) for diabetic patients with hyperlipidemia. Both drugs significantly ameliorated blood glucose and lipid levels and shifted the gut microbiota. <italic>Blautia</italic> spp. were identified as being associated with improvements in glucose and lipid homeostasis for both drugs. AMC exerted larger effects on the gut microbiota together with better efficacies in improving HOMA-IR and plasma triglyceride levels, which were associated with the enrichment of <italic>Faecalibacterium</italic> spp. In brief, these data suggest that gut microbiota might be involved in the alleviation of diabetes with hyperlipidemia by metformin and the AMC herbal formula.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>clinical trial</kwd><kwd>gut microbiota</kwd><kwd>hyperlipidemia</kwd><kwd>metformin</kwd><kwd>traditional Chinese medicine</kwd><kwd>type 2 diabetes</kwd></kwd-group><funding-group><award-group id="award1"><funding-source><institution-wrap><institution>Scientific Specialized Program of Traditional Chinese Medicine of China</institution></institution-wrap></funding-source><award-id>201007004</award-id><principal-award-recipient><name><surname>Tong</surname><given-names>Xiaolin</given-names></name></principal-award-recipient></award-group><award-group id="award2"><funding-source><institution-wrap><institution>National Natural Science Foundation of China (NSFC)</institution><institution-id>https://doi.org/10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>31330005</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Liping</given-names></name></principal-award-recipient></award-group><award-group id="award3"><funding-source><institution-wrap><institution>National Natural Science Foundation of China (NSFC)</institution><institution-id>https://doi.org/10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>81273720</award-id><principal-award-recipient><name><surname>Tong</surname><given-names>Xiaolin</given-names></name></principal-award-recipient></award-group><award-group id="award4"><funding-source><institution-wrap><institution>National Natural Science Foundation of China (NSFC)</institution><institution-id>https://doi.org/10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>81401141</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Chenhong</given-names></name></principal-award-recipient></award-group></funding-group><counts><count count="9" count-type="supplementary-material"/><fig-count count="4"/><table-count count="0"/><equation-count count="0"/><ref-count count="56"/><page-count count="12"/><word-count count="8254"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>May/June 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s0"><title>INTRODUCTION</title><p>Type 2 diabetes mellitus (T2DM), a global epidemic disease with a rapid growth in rates of incidence and prevalence, affects people from all income levels worldwide (<xref rid="B1" ref-type="bibr">1</xref>). It is a metabolic disease characterized by insulin resistance and &#x003b2;-cell dysfunction (<xref rid="B2" ref-type="bibr">2</xref>) associated with inflammation caused by overnutrition and other environmental factors (<xref rid="B3" ref-type="bibr">3</xref><xref ref-type="bibr" rid="B4">&#x02013;</xref><xref rid="B5" ref-type="bibr">5</xref>). The intestinal microbiota has been proposed to play a vital role in the pathophysiology of obesity, T2DM, and other metabolic diseases (<xref rid="B6" ref-type="bibr">6</xref><xref ref-type="bibr" rid="B7">&#x02013;</xref><xref rid="B8" ref-type="bibr">8</xref>). Transplantation of the gut microbiota from the obese human gut can transfer the obese phenotypes to germfree mice, indicating the causative role of gut microbiota in the development of obesity and metabolic diseases (<xref rid="B7" ref-type="bibr">7</xref>). Moreover, an opportunistic pathogen, <named-content content-type="genus-species">Enterobacter cloacae</named-content> B29, isolated from a diabetic obese human&#x02019;s gut, can induce obesity and insulin resistance in germfree mice (<xref rid="B9" ref-type="bibr">9</xref>). These findings disclosed that gut microbiota can causatively arouse insulin resistance, obesity, and T2DM. Furthermore, a more recent study showed that dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children (<xref rid="B10" ref-type="bibr">10</xref>). Therefore, targeting the gut microbiota with prebiotics, probiotics, diets, and drugs would be a novel therapeutic approach to ameliorate diabetes, hyperlipidemia, and other metabolic diseases.</p><p>Metformin is one of the most widely used oral antihyperglycemic drugs recommended as the first-line remedy for the treatment of diabetes. It also shows potential applications in the treatment or prevention of hyperlipidemia (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>) and cardiovascular diseases (<xref rid="B13" ref-type="bibr">13</xref>). Numerous studies showed that metformin might function by inhibition of hepatic gluconeogenesis via activation of the AMP-activated protein kinase (AMPK) signaling pathway (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). However, in contrast to oral dosing, intravenously administered metformin does not improve glucose metabolism (<xref rid="B16" ref-type="bibr">16</xref>), indicating that gut microbiota might be the target. A more recent study demonstrated that metformin enriched the <italic>Akkermansia</italic> sp. population in high-fat-diet (HFD)-induced hyperglycemic and hyperlipidemic mice. Moreover, an inoculum of <italic>Akkermansia</italic> administered to diabetic mice exhibited a similar glucose-lowering efficacy to metformin, suggesting that alteration of gut microbiota is a new mechanism of metformin&#x02019;s therapeutic effect in treatment of diabetes (<xref rid="B17" ref-type="bibr">17</xref>). However, our study showed that metformin significantly increased short-chain fatty acid (SCFA)-producing bacteria such as <italic>Blautia</italic> spp. and decreased <italic>Akkermansia</italic> spp., together with the amelioration of obesity in HFD-induced rats (<xref rid="B18" ref-type="bibr">18</xref>). As for in humans, when using metagenomic data from a multicountry T2DM metagenomic data set, univariate tests showed a significant increase in <italic>Escherichia</italic> spp. and a reduced abundance of <italic>Intestinibacter</italic> spp. in T2DM metformin-treated samples (<xref rid="B19" ref-type="bibr">19</xref>). However, this was the analysis of a collected microbial data set rather than a metformin-mediated gut microbiota shift analysis in a randomized clinical trial. Therefore, investigations with randomized clinical trials are needed to better understand metformin&#x02019;s effect on gut bacteria in humans.</p><p>Traditional Chinese medicine (TCM) is a form of polypharmacy that has been developed and advocated for the treatment of many diseases for over 2,500&#x000a0;years in China. Our previous study suggested that gut microbiota might be involved in the effect of a standardized traditional herbal formula, GQD, which indicated that TCM can also modulate gut microbiota structure as a potential mechanism for improvement of diseases (<xref rid="B20" ref-type="bibr">20</xref>). An herbal formula consisting of eight herbs (AMC) was specifically developed for type 2 diabetic patients with hyperlipidemia. The herbs used in this formula, such as <italic>Rhizoma Anemarrhenae</italic> (<xref rid="B21" ref-type="bibr">21</xref>), <named-content content-type="genus-species">Momordica charantia</named-content> (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>), <named-content content-type="genus-species">Coptis chinensis</named-content> (<xref rid="B24" ref-type="bibr">24</xref>), <named-content content-type="genus-species">Aloe vera</named-content> (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), and red yeast rice (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>), have profound effects in ameliorating blood glucose and lipid levels in various clinical trials and animal experiments. In addition, this herbal formula has been used in clinical application for more than 10&#x000a0;years, which displayed satisfying efficacy. AMC contains the herb <named-content content-type="genus-species">Coptis chinensis</named-content>, whose major component, berberine, has been clinically demonstrated to be able to alleviate diabetes with hyperlipidemia, possibly via increasing SCFA-producing bacteria as shown in rats with HFD-induced obesity (<xref rid="B29" ref-type="bibr">29</xref>). We hypothesized that gut microbiota might also be involved in the efficacy of AMC.</p><p>To test the hypothesis that alteration of gut microbiota may be involved in the alleviation of T2DM with hyperlipidemia by metformin and AMC, 450 patients with T2DM and hyperlipidemia were randomly assigned to ether a metformin- or AMC-treated group. After 12&#x000a0;weeks of treatment, 100 patients were randomly selected from each group and assessed for clinical improvements. The effects of the two drugs on the intestinal microbiota were evaluated by analyzing the V3 and V4 regions of the 16S rRNA gene by Illumina sequencing and multivariate statistical analysis.</p></sec><sec sec-type="results" id="s1"><title>RESULTS</title><sec id="s1.1"><title>Alleviation of hyperglycemia and hyperlipidemia by metformin and AMC.</title><p>We analyzed the clinical data from 200 participants as shown in <xref ref-type="supplementary-material" rid="tabS2">Table&#x000a0;S2</xref>&#x000a0;in the supplemental material. The baseline variables showed no significant differences between the two groups. After 12&#x000a0;weeks of treatment, both metformin and AMC significantly improved fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), 2-h postprandial blood glucose (PBG), and homeostatic model assessment of &#x003b2;-cell function (HOMA-&#x003b2;). However, only AMC significantly improved homeostatic model assessment of insulin resistance (HOMA-IR), although no significant difference was obtained between AMC and metformin by analysis of covariance (ANCOVA). There were no significant differences between the two treatment groups in the alleviation of diabetes, except that insulin resistance was only significantly improved by AMC (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1a</xref> to <xref ref-type="fig" rid="fig1">e</xref>; <xref ref-type="supplementary-material" rid="tabS2">Table&#x000a0;S2</xref>). Besides, the AMC herbal formula significantly reduced total plasma cholesterol, triglyceride, and low-density lipoprotein cholesterol (LDL-c) levels, body weight, body mass index (BMI), and waist and hip circumferences of diabetic patients with hyperlipidemia (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1f</xref> to <xref ref-type="fig" rid="fig1">h</xref>; see <xref ref-type="supplementary-material" rid="figS2">Fig.&#x000a0;S2a</xref> to <xref ref-type="supplementary-material" rid="figS2">d</xref> and <xref ref-type="supplementary-material" rid="tabS2">Table&#x000a0;S2</xref>&#x000a0;in the supplemental material). These parameters were also significantly ameliorated by metformin, except for triglyceride levels. However, metformin significantly increased diastolic blood pressure unexpectedly, which was significantly higher than that by AMC according to ANCOVA (<xref ref-type="supplementary-material" rid="figS2">Fig.&#x000a0;S2e</xref> and <xref ref-type="supplementary-material" rid="figS2">f</xref>).</p><supplementary-material content-type="local-data" id="figS1"><object-id pub-id-type="doi">10.1128/mBio.02392-17.2</object-id><label>FIG&#x000a0;S1&#x000a0;</label><p>The AMC herbal formula. (a) Photos of the boil-free granules of 8 herbs in the AMC herbal formula. (b) HPLC fingerprinting of AMC herbal formula. (c) Eight main chemicals in AMC. Download <inline-supplementary-material id="figs1" mimetype="image" mime-subtype="tiff" xlink:href="mbo003183901sf1.tif" content-type="local-data">FIG&#x000a0;S1, TIF file, 1.5 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="figS2"><object-id pub-id-type="doi">10.1128/mBio.02392-17.3</object-id><label>FIG&#x000a0;S2&#x000a0;</label><p>The effect of metformin and AMC herbal formula on body weight and blood pressure of T2D patients with dyslipidemia. MET, metformin; AMC, AMC herbal formula. ***, <italic>P</italic> &#x0003c; 0.0001, and *, <italic>P</italic> &#x0003c; 0.05, using the paired <italic>t</italic>&#x000a0;test; <sup>+</sup>, <italic>P</italic> &#x0003c; 0.05 using ANCOVA. Data are presented as means &#x000b1; SEM. Download <inline-supplementary-material id="figs2" mimetype="image" mime-subtype="tiff" xlink:href="mbo003183901sf2.tif" content-type="local-data">FIG&#x000a0;S2, TIF file, 0.4 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="tabS1"><object-id pub-id-type="doi">10.1128/mBio.02392-17.7</object-id><label>TABLE&#x000a0;S1&#x000a0;</label><p>Composition of the AMC herbal formula. Download <inline-supplementary-material id="tabs1" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="mbo003183901st1.docx" content-type="local-data">TABLE&#x000a0;S1, DOCX file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="tabS2"><object-id pub-id-type="doi">10.1128/mBio.02392-17.8</object-id><label>TABLE&#x000a0;S2&#x000a0;</label><p>Demographic, baseline, and study endpoint characteristics of clinical parameters. Download <inline-supplementary-material id="tabs2" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="mbo003183901st2.docx" content-type="local-data">TABLE&#x000a0;S2, DOCX file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><fig id="fig1" orientation="portrait" position="float"><label>FIG&#x000a0;1&#x000a0;</label><caption><p>Both metformin and AMC herbal formula significantly improved glucose and lipid homeostasis of T2DM patients with hyperlipidemia. (a) Fasting blood glucose. (b) HbA1c. (c) Two-hour postprandial blood glucose. (d) Homeostasis model assessment of insulin resistance (HOMA-IR). (e) Homeostasis model assessment of &#x003b2;-cell function (HOMA-&#x003b2;). (f) Cholesterol. (g) Triglyceride. (h) LDL-c. Data are presented as means &#x000b1; standard errors of the means (SEM). MET, metformin; AMC, AMC herbal formula. ***, <italic>P</italic> &#x0003c; 0.0001, **, <italic>P</italic> &#x0003c; 0.001, *, <italic>P</italic> &#x0003c; 0.01, and +, <italic>P</italic> &#x0003c; 0.05, by two-tailed paired <italic>t</italic>&#x000a0;test.</p></caption><graphic xlink:href="mbo0031839010001"/></fig></sec><sec id="s1.2"><title>Alteration of gut microbiota structure by metformin and AMC.</title><p>To analyze the structural changes of gut microbiota in T2DM patients treated with metformin and the AMC herbal formula, we performed Illumina sequencing of the V3 and V4 regions of the 16S rRNA gene using fecal samples collected at weeks 0 and 12 in the metformin and AMC treatment groups. Altogether, we got 6,216,877 high-quality sequences and 507 operational taxonomic units (OTUs) from 372 samples, with an average of 16,712 &#x000b1; 3,663 reads. (One sample was excluded in later analysis because only 1,891 reads were obtained.) The &#x003b1; diversity of the gut microbiota community showed that metformin significantly increased Simpson&#x02019;s diversity index, while AMC significantly decreased rarefaction and Chao1 richness estimates, indicating that metformin significantly increased diversity, whereas AMC significantly reduced it (see <xref ref-type="supplementary-material" rid="figS3">Fig.&#x000a0;S3</xref> in the supplemental material). Principal-component analysis (PCA) and principal-coordinate analysis (PCoA) based on Bray-Curtis distance showed that both metformin and AMC significantly changed the gut microbiota structure of T2DM patients (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2</xref>). As for the PCoA results based on weighted and unweighted UniFrac distances and abundance-weighted and binary Jaccard distances, they displayed similar values, although the effect of metformin did not reach a significant level (see <xref ref-type="supplementary-material" rid="figS4">Fig.&#x000a0;S4</xref> in the supplemental material). Furthermore, comparing the changes of five distances before and after treatments using the Mann-Whitney <italic>U</italic>&#x000a0;test, AMC exerted a significant larger modulating effect on the gut microbiota structure (see <xref ref-type="supplementary-material" rid="figS5">Fig.&#x000a0;S5</xref> in the supplemental material).</p><supplementary-material content-type="local-data" id="figS3"><object-id pub-id-type="doi">10.1128/mBio.02392-17.4</object-id><label>FIG&#x000a0;S3&#x000a0;</label><p>Effects of metformin and AMC herbal formula treatment on the diversity of the gut microbiota. (a) OTU estimates via rarefaction analysis. (b) Chao1 richness estimates. (c) Shannon-Wiener index. (d) Simpson&#x02019;s index. Wilcoxon&#x02019;s test is performed for comparison between the before and after treatment groups using the diversity calculation results under the same sequencing depth of 5,010. Data are presented as means &#x000b1; SEM. *, <italic>P</italic> &#x0003c; 0.05; **, <italic>P</italic> &#x0003c; 0.01; ***, <italic>P</italic> &#x0003c; 0.001. Download <inline-supplementary-material id="figs3" mimetype="image" mime-subtype="tiff" xlink:href="mbo003183901sf3.tif" content-type="local-data">FIG&#x000a0;S3, TIF file, 0.6 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="figS4"><object-id pub-id-type="doi">10.1128/mBio.02392-17.5</object-id><label>FIG&#x000a0;S4&#x000a0;</label><p>Overall structural alterations of gut microbiota by metformin and AMC herbal formula treatments in type 2 diabetic patients. (a, c, e, and g) Principal-coordinate analysis score plot based on weighted and unweighted UniFrac distances and abundance-weighted and binary Jaccard distances. Each point represents the mean principal-coordinate score of all patients in a group at one time point, and the error bar represents the SEM. (b, d, f, and h) Clustering of gut microbiota based on the distances calculated using MANOVA with weighted and unweighted UniFrac distances and abundance-weighted and binary Jaccard PCoA scores. ***, <italic>P</italic> &#x0003c; 0.0001. Download <inline-supplementary-material id="figs4" mimetype="image" mime-subtype="tiff" xlink:href="mbo003183901sf4.tif" content-type="local-data">FIG&#x000a0;S4, TIF file, 0.2 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="figS5"><object-id pub-id-type="doi">10.1128/mBio.02392-17.6</object-id><label>FIG&#x000a0;S5&#x000a0;</label><p>Larger alteration of gut microbiota structure by AMC herbal formula than by metformin in type 2 diabetic patients. (a and b) Weighted and unweighted UniFrac distances. (c) Bray-Curtis distance. (d and e) Abundance-weighted and binary Jaccard distances. MET, metformin; AMC, AMC herbal formula. The box extends from the 25th to 75th percentiles. The upper (or lower) whisker extends from the top of the box to the highest (or lowest) value within 1.5 times the interquartile range. *, <italic>P</italic> &#x0003c; 0.05, and **, <italic>P</italic> &#x0003c; 0.01, using the Mann-Whitney <italic>U</italic>&#x000a0;test. Download <inline-supplementary-material id="figs5" mimetype="image" mime-subtype="tiff" xlink:href="mbo003183901sf5.tif" content-type="local-data">FIG&#x000a0;S5, TIF file, 0.6 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><fig id="fig2" orientation="portrait" position="float"><label>FIG&#x000a0;2&#x000a0;</label><caption><p>Both metformin and AMC herbal formula significantly altered the overall gut microbiota structure in T2DM patients with hyperlipidemia. (a) Principal-component analysis score plot. (c) Principal-coordinate analysis score plot based on Bray-Curtis distance. Each point represents the mean principal-coordinate score of all patients in a group at one time point, and the error bar represents the SEM. (b and d) Clustering of gut microbiota based on the distances calculated using MANOVA with PCA scores and Bray-Curtis PCoA scores. ****, <italic>P</italic> &#x0003c; 0.0001; *, <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="mbo0031839010002"/></fig></sec><sec id="s1.3"><title>CAGs associated with the improvements in glucose and lipid homeostasis.</title><p>To find the key phylotypes that correlated with the efficacy of metformin and the AMC herbal formula, coabundant network analysis was used in this study. The 214 core OTUs (which existed in &#x0003e;20% samples) were clustered into 24 coabundant groups (CAGs) by SparCC correlation and permutational multivariate analysis of variance (PERMANOVA). Twenty-one CAGs containing OTUs with <italic>R</italic>&#x000a0;values of &#x0003e;0.4 were displayed in the coabundant network (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3a</xref>).</p><fig id="fig3" orientation="portrait" position="float"><label>FIG&#x000a0;3&#x000a0;</label><caption><p>Alterations of coabundant groups by metformin and AMC herbal formula treatments. (a) Coabundant network analysis. Each circle represents one OTU. Circles with the same color are from the same coabundant group (CAG). Circle size represents the average abundance of each OTU in each group. (b) Relative abundance of altered CAGs by metformin and/or the AMC herbal formula. The relative abundances of CAGs are expressed as means &#x000b1; standard deviations (SD). ***, <italic>P</italic> &#x0003c; 0.001, **, <italic>P</italic> &#x0003c; 0.01, and *, <italic>P</italic> &#x0003c; 0.05, by Wilcoxon&#x02019;s signed-rank test.</p></caption><graphic xlink:href="mbo0031839010003"/></fig><p>In the metformin treatment group, four CAGs were increased by metformin and three were significantly decreased (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3b</xref>; see <xref ref-type="supplementary-material" rid="tabS3">Table&#x000a0;S3</xref>&#x000a0;in the supplemental material). Among the four CAGs enriched by metformin, CAG21 showed significant inverse correlations with HbA1c, and CAG25 with FBG, 2-h PBG, and LDL-c (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4a</xref>). CAG21 consisted of 10 OTUs: two OTUs belong to <italic>Clostridium</italic> XIVa and one to each of the following genera: <named-content content-type="genus-species">Erysipelotrichaceae incertae</named-content>
<italic>sedis</italic>, <italic>Escherichia</italic>/<italic>Shigella</italic>, <italic>Fusobacterium</italic>, <italic>Flavonifractor</italic>, <italic>Lachnospiraceae</italic>, <named-content content-type="genus-species">Lachnospiracea incertae</named-content>
<italic>sedis</italic>, and <italic>Clostridium</italic> XVIII and IV. CAG25 contained four OTUs from <italic>Blautia</italic> and one from <italic>Anaerostipes</italic>. Among the three CAGs inhibited by metformin, CAG7 and CAG8 were significantly correlated with the alleviation of hyperglycemia (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4a</xref>). CAG7 and -8 showed significantly negative correlations with HOMA-&#x003b2;. CAG7 contained three OTUs from <italic>Bacteroides</italic> and one from <italic>Parabacteroides</italic>; CAG8 consisted of three OTUs from <italic>Bacteroides</italic>, two OTUs from <italic>Alistipes</italic>, and one OTU each from <italic>Oscillibacter</italic> and un-<italic>Ruminococcaceae</italic>, respectively. To sum up, metformin significantly enriched CAG21 and CAG25 and inhibited CAG7 and CAG8, which were significantly correlated with the amelioration of hyperglycemia and hyperlipidemia.</p><supplementary-material content-type="local-data" id="tabS3"><object-id pub-id-type="doi">10.1128/mBio.02392-17.9</object-id><label>TABLE&#x000a0;S3&#x000a0;</label><p>Taxonomy and relative abundance of the 14 key CAGs. Download <inline-supplementary-material id="tabs3" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="mbo003183901st3.docx" content-type="local-data">TABLE&#x000a0;S3, DOCX file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><fig id="fig4" orientation="portrait" position="float"><label>FIG&#x000a0;4&#x000a0;</label><caption><p>Association of the key CAGs changed by metformin or the AMC herbal formula with improvements in glucose and lipid homeostasis. (a) Key CAGs associated with the efficacy of metformin. (b) Key CAGs associated with the efficacy of the AMC herbal formula. The <italic>R</italic>&#x000a0;value is shown as a heat map. +, <italic>P</italic> &#x0003c; 0.05 by Spearman&#x02019;s correlation. The names of genera of the representative OTUs of each CAG are labeled to the right.</p></caption><graphic xlink:href="mbo0031839010004"/></fig><p>After the AMC herbal formula treatment, six CAGs were increased and five were decreased (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3b</xref>; <xref ref-type="supplementary-material" rid="tabS3">Table&#x000a0;S3</xref>). Among the six CAGs enriched by AMC herbal formula, CAG5, CAG13, CAG24, and CAG25 showed significant positive correlations with the improvement of glucose and lipid homeostasis (<xref ref-type="fig" rid="fig4">Fig.&#x000a0;4b</xref>). CAG5 was inversely correlated with HOMA-IR, which contained two OTUs from <italic>Megamonas</italic>. CAG13 has the highest relative abundance, with OTU2 from <italic>Faecalibacterium</italic> accounting for over 50%. It showed significant negative correlations with HbA1c, FBG, 2-h PBG, HOMA-IR, and triglyceride levels, which consisted of two OTUs from <italic>Roseburia</italic>, and one OTU each from <italic>Faecalibacterium</italic>, <italic>Gemmiger</italic>, <italic>Coprococcus</italic>, and un-<italic>Lachnospiraceae</italic>, respectively. CAG24 also showed inverse correlations with FBG, 2-h PBG, HOMA-IR, and triglyceride levels, which contained two OTUs from un-<italic>Lachnospiraceae</italic> and one OTU from <italic>Ruminococcus</italic> 2 and <named-content content-type="genus-species">Lachnospiracea incertae</named-content>
<italic>sedis</italic>, respectively. CAG25 was inversely correlated with HOMA-IR and triglyceride levels, and it contained four OTUs from <italic>Blautia</italic> and one from <italic>Anaerostipes</italic>, as described above. Taken together, AMC herbal formula significantly enriched CAG5, CAG13, CAG24, and CAG25, which showed significant correlations with the improvements of hyperglycemia and hyperlipidemia.</p><p>We compared the key CAGs that responded to metformin and the AMC herbal formula and tried to find the common CAGs shared by the two drugs. These CAGs might be related to the alleviation of diabetes rather than simply responding to the drug treatment. Among the eight CAGs that were associated with the efficacy of metformin or the AMC herbal formula, CAG25, represented by the OTU from <italic>Blautia</italic>, was identified in both drug treatment groups.</p></sec></sec><sec sec-type="discussion" id="s2"><title>DISCUSSION</title><p>To our knowledge, this is the first randomized clinical trial evaluating a traditional Chinese herbal formula&#x02019;s efficacy in treating T2DM with hyperlipidemia and obesity using metformin as a positive control. In the 12&#x000a0;weeks of clinical trial, both drugs significantly ameliorated hyperglycemia and hyperlipidemia, but only AMC significantly improved triglyceride levels. This is consistent with a meta-analysis of randomized controlled clinical trials in which metformin had no intrinsic effect on triglyceride levels in T2DM patients (<xref rid="B30" ref-type="bibr">30</xref>). To sum up, AMC displayed a slightly better effect in the alleviation of hyperglycemia and hyperlipidemia as only AMC significantly improved diabetic patients&#x02019; HOMA-IR and plasma triglyceride levels.</p><p>In this clinical trial, an alteration of gut microbial structure by metformin in humans was observed. Metformin treatment significantly inhibited two functional groups, namely, CAG7 and CAG8, which contained potential pathogen-like genera, including <italic>Alistipes</italic>, <italic>Oscillibacter</italic>, and <italic>Bacteroides</italic>. In addition, the reductions in the two CAGs significantly correlated with the improvement of glucose homeostasis by metformin. Members of <italic>Alistipes</italic> were positively associated with the colonic tumorigenesis in gnotobiotic mice into which were transplanted the gut microbiota from colorectal cancer patients (<xref rid="B31" ref-type="bibr">31</xref>). Furthermore, elevation of several OTUs from <italic>Alistipes</italic> was correlated with a greater frequency of pain in pediatric patients with irritable bowel syndrome (<xref rid="B32" ref-type="bibr">32</xref>). As for <italic>Oscillibacter</italic>, transferring the gut microbiota of obesity-prone rats harboring specific species from <italic>Oscillibacter</italic> and <italic>Clostridium</italic> clusters IV to germfree mice replicated the obese phenotypes and associated disordered signaling pathways (<xref rid="B33" ref-type="bibr">33</xref>). These results suggest that inhibition of potential pathogen-like bacteria might be involved in the glucose-lowering effect of metformin.</p><p>The present study observed the increase in <italic>Blautia</italic> spp., a population of SCFA producers in the metformin-treated group, in agreement with our previous animal study (<xref rid="B18" ref-type="bibr">18</xref>). Interestingly, we observed a decrease in <italic>Akkermansia</italic> in T2DM patients after metformin treatment. This finding confirmed our results in Wistar rats with HFD-induced insulin resistance and obesity treated with metformin (<xref rid="B18" ref-type="bibr">18</xref>), but it was contrary to the previous study that metformin specifically increased <italic>Akkermansia</italic> spp. and thus improved glucose homeostasis in mice with HFD-induced obesity (<xref rid="B17" ref-type="bibr">17</xref>). This might be attributed to the differences in strain-specific functions. To further dissect the gut microbiota-mediated mechanism of metformin in the later study, we first tried to identify the key population that responds to metformin in a randomized clinical trial.</p><p>AMC increased functional groups CAG5 and CAG13, which were significantly correlated with the improvements in glucose and lipid homeostasis. They contained OTUs from <italic>Faecalibacterium</italic>, <italic>Roseburia</italic>, <italic>Gemmiger</italic>, <italic>Coprococcus</italic>, and <italic>Megamonas</italic>. <italic>Faecalibacterium</italic> and <italic>Roseburia</italic> are two genera containing butyrate-producing bacteria (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). <named-content content-type="genus-species">Faecalibacterium prausnitzii</named-content> is an anti-inflammatory (<xref rid="B36" ref-type="bibr">36</xref>) and functionally important bacterium (<xref rid="B37" ref-type="bibr">37</xref>). Several recent studies showed that <named-content content-type="genus-species">F.&#x000a0;prausnitzii</named-content> and its supernatant prevented the physiological damage to the intestine induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B38" ref-type="bibr">38</xref>) or dextran sodium sulfate (DSS) (<xref rid="B39" ref-type="bibr">39</xref>) in mice, possibly through the production of butyrate, salicylic acids (<xref rid="B40" ref-type="bibr">40</xref>), or an anti-inflammatory molecule (<xref rid="B41" ref-type="bibr">41</xref>). The gut metagenome analysis showed that T2DM patients had lower levels of butyrate-producing bacteria, such as <italic>Roseburia</italic> and <named-content content-type="genus-species">F.&#x000a0;prausnitzii</named-content>, in the cohorts of Chinese diabetics and European diabetic women (<xref rid="B42" ref-type="bibr">42</xref><xref ref-type="bibr" rid="B43">&#x02013;</xref><xref rid="B44" ref-type="bibr">44</xref>). It has been reported that a higher abundance of <named-content content-type="genus-species">F.&#x000a0;prausnitzii</named-content> was linked with the reduction of a low-grade inflammatory state during the alleviation of obesity and diabetes in patients receiving Roux-en-Y gastric bypass (RYGB) surgery (<xref rid="B45" ref-type="bibr">45</xref>). Moreover, according to our previous study, an increase in <named-content content-type="genus-species">F.&#x000a0;prausnitzii</named-content> was associated with the alleviation of diabetes by another Chinese herbal formula, GQD, in a double-blinded, placebo-controlled clinical trial (<xref rid="B20" ref-type="bibr">20</xref>). <italic>Faecalibacterium</italic> was also recovered after the treatment of AMC in this study, indicating that <italic>Faecalibacterium</italic> spp. might be important in the efficacy of the TCM formula in the improvements in diabetes and obesity.</p><p><italic>Roseburia</italic>, <italic>Gemmiger</italic>, and <italic>Coprococcus</italic> enriched by the AMC herbal formula in T2DM patients are also reported to have beneficial influences. Besides, restoration of <italic>Roseburia</italic> spp. by chitin-glucan fiber was related with alleviations of obesity, diabetes, and hepatic steatosis in mice fed with HFD (<xref rid="B46" ref-type="bibr">46</xref>). These results showed that enrichment of SCFA-producing bacteria might be associated with the amelioration of hyperglycemia and hyperlipidemia by AMC.</p><p>Notably, CAG25 dominated by OTUs from <italic>Blautia</italic> was significantly increased by both drugs and correlated with the improvements in glucose and lipid homeostasis. <italic>Blautia</italic> is a group of bacteria containing various acetate and butyrate producers (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). More importantly, <italic>Blautia</italic> spp. were also reported to be enriched by metformin during the amelioration of obesity and insulin resistance in rats (<xref rid="B18" ref-type="bibr">18</xref>). It has been reported that 16 children with type 1 diabetes possessed a significantly lower abundance of <named-content content-type="genus-species">Blautia coccoides</named-content> with respect to 16 healthy children by PCR-denaturing gradient gel electrophoresis (DGGE) and real-time quantitative PCR (qPCR) (<xref rid="B49" ref-type="bibr">49</xref>). Moreover, according to the gut microbial structure analysis of 64 patients receiving blood/marrow transplantation, a larger amount of anti-inflammatory <italic>Blautia</italic> spp. was associated with a reduction in mortality caused by acute graft-versus-host disease after the surgery. This result was further confirmed in another independent cohort with 51 patients enrolled from the same institution (<xref rid="B50" ref-type="bibr">50</xref>). These results suggest that <italic>Blautia</italic> spp. might be a common target for the management of diabetes with hyperlipidemia.</p><p>Compared with metformin, AMC exerted a much stronger modulatory effect on the gut microbiota together with better efficacy in improving HOMA-IR and triglyceride levels. This might be attributed to the effects of multiple chemical components in the AMC, such as mangiferin and berberine. In a randomized, double-blind clinical trial, mangiferin treatment significantly improved serum levels of triglycerides, free fatty acids, and HOMA-IR in overweight patients with hyperlipidemia (<xref rid="B51" ref-type="bibr">51</xref>), but the pharmacological mechanism of mangiferin has not been elucidated yet. Another study showed that gut microbiota might play an important role in it despite its poor absorption in the gastrointestinal tract. <italic>Bacteroides</italic> sp. strain MANG might be responsible for the pharmacological effects of mangiferin via converting it into its aglycone and norathyriol (<xref rid="B52" ref-type="bibr">52</xref>). Berberine was reported to significantly improve hyperglycemia and hyperlipidemia in a multicenter, randomized, double-blind, and placebo-controlled clinical trial (<xref rid="B24" ref-type="bibr">24</xref>). In addition, berberine prevented and alleviated HFD-induced obesity and insulin resistance in rats through enrichment of SCFA producers such as <italic>Blautia</italic> spp. (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B29" ref-type="bibr">29</xref>). These findings implied that mangiferin and berberine might be the major active ingredients in AMC that shifted the gut microbiota.</p><sec id="s2.1" sec-type="conclusions"><title>Conclusion.</title><p>Taken together, these data suggest that metformin and the Chinese herbal formula may ameliorate type 2 diabetes with hyperlipidemia by enriching beneficial bacteria, such as <italic>Blautia</italic> and <italic>Faecalibacterium</italic> spp.</p></sec></sec><sec sec-type="materials|methods" id="s3"><title>MATERIALS AND METHODS</title><sec id="s3.1"><title>Study design.</title><p>This study was a multicenter, randomized, positive-control, and open label clinical trial, including a 4-week washout period and a 12-week treatment period. It was performed according to the Declaration of Helsinki (2008) and approved by the Ethics Committee of Guang&#x02019;anmen Hospital of the China Academy of Chinese Medical Sciences (approval no. eighty-sixth 2011). All participants signed informed consent forms before enrolling in the study (Clinicaltrials.gov registration no. <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/results?term=NCT01471275">NCT01471275</ext-link>). The inclusion and exclusion criteria are stated in <xref ref-type="supplementary-material" rid="textS1">Text&#x000a0;S1</xref>&#x000a0;in the supplemental material.</p><supplementary-material content-type="local-data" id="textS1"><object-id pub-id-type="doi">10.1128/mBio.02392-17.1</object-id><label>TEXT&#x000a0;S1&#x000a0;</label><p>Supplemental materials and methods. Download <inline-supplementary-material id="texts1" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="mbo003183901s1.docx" content-type="local-data">TEXT&#x000a0;S1, DOCX file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2018 Tong et al.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tong et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>In the initial screening, a 75-g oral glucose tolerance test (OGTT) was used for diagnosis of diabetes, and plasma triglyceride levels, waist circumference, and hip circumference were used for diagnosis of hyperlipidemia. After a 4-week washout period, 450 patients with T2DM and hyperlipidemia were enrolled in the clinical trial. They were randomized into two treatment groups, receiving either metformin or TCM. Randomization was performed centrally and stratified in the proportion of 1:1 for the two treatment groups through the Interactive Web Response System by a third party not involved in data management and statistical analysis. After a 12-week treatment, 100 patients were randomly chosen from either treatment group. The random assignment was generated by the computer program SAS 9.3, which was also conducted by independent statisticians who did not participate in data acquisition and evaluation. All of the recruited patients followed advice on diabetic and low-fat diets and exercises for diabetic patients as instructed by the Chinese Diabetes Society.</p></sec><sec id="s3.2"><title>Drug administration.</title><p>The TCM formula in our study was the AMC herbal formula composed of 8 herbs, namely, <italic>Rhizoma Anemarrhenae</italic>, <named-content content-type="genus-species">Momordica charantia</named-content>, <named-content content-type="genus-species">Coptis chinensis</named-content>, <named-content content-type="genus-species">Salvia miltiorrhiza</named-content>, red yeast rice, <named-content content-type="genus-species">Aloe vera</named-content>, <named-content content-type="genus-species">Schisandra chinensis</named-content>, and dried ginger. Herbs were all provided by Jiangyin Tianjiang Pharmaceutical Co., Ltd., and quality controlled. All the herbs were processed into boil-free granules (see <xref ref-type="supplementary-material" rid="textS1">Text&#x000a0;S1</xref>&#x000a0;and <xref ref-type="supplementary-material" rid="figS1">Fig.&#x000a0;S1</xref> in the supplemental material). <xref ref-type="supplementary-material" rid="tabS1">Table&#x000a0;S1</xref>&#x000a0;in the supplemental material lists the amount of granular extracts of each herb in 1 unit of AMC formula the patients had daily. Patients mixed the eight granular extracts and took them like coffee twice daily.</p><p>Patients in the positive-control group took metformin hydrochloride tablets, which were all provided by Beijing Liling Hengtai Pharmaceutical Co., Ltd., and quality controlled (approval no. H11021560). They took metformin tablets 0.25&#x000a0;g/time and 3 times/day orally after meals.</p></sec><sec id="s3.3"><title>Study evaluation and outcomes.</title><p>The primary efficacy outcomes were glycosylated hemoglobin (HbA1c), triglyceride (TG), weight, and waist circumference. Secondary efficacy outcomes were fasting blood glucose (FBG), 2-h postprandial blood glucose (2-h PBG), serum insulin, total cholesterol, high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c). The adverse events and the occurrence of hypoglycemia were recorded. FBG, weight, and waist circumference were detected every 4&#x000a0;weeks; other assessments were performed before and after the treatment. Fecal samples were collected by using InviMag stool collection tubes with DNA stabilizer (Invitek, Germany) for gut microbiota analysis before and after the treatment.</p></sec><sec id="s3.4"><title>DNA extraction and V3 and V4 regions of 16S rRNA gene sequencing.</title><p>Total genomic DNA of fecal samples was extracted by the InviMag stool DNA kit (Invitek, Germany) as previously described (<xref rid="B20" ref-type="bibr">20</xref>). The sequencing library of the V3 and V4 regions of the 16S rRNA gene was prepared following the protocol from Illumina, Inc., with minor modification (<xref rid="B53" ref-type="bibr">53</xref>). Before the sequencing, 40% Phix (PhiX control kit v3; Illumina, Inc.) was added to the pooled library to serve as an internal control. The pooled library was sequenced on the Illumina MiSeq System using paired-end 300-bp reads and the MiSeq v3 reagent kit.</p></sec><sec id="s3.5"><title>Bioinformatics analysis of sequencing data.</title><p>High-quality sequencing data extraction was performed as follows (<xref rid="B54" ref-type="bibr">54</xref>). (i) Both ends of the forward and reverse reads were truncated at the base, where the Phred quality score was no more than 20. (ii) If the forward and reverse reads had a minimum 50-bp-length overlap, they could be merged into a complete read. (iii) These reads were not kept unless they were longer than 399&#x000a0;bp and the expected errors were less than 0.5. Operational taxonomic units (OTUs) were delineated at the cutoff of 97% using the USEARCH v.7.0.1090 pipeline. The protocol can be found on the website <ext-link ext-link-type="uri" xlink:href="http://drive5.com/usearch/manual/uparse_pipeline.html">http://drive5.com/usearch/manual/uparse_pipeline.html</ext-link>. The detailed procures were stated in our previous publication (<xref rid="B53" ref-type="bibr">53</xref>). &#x003b1;- and &#x003b2;-diversity analyses were performed using QIIME v1.8.0 (<xref rid="B55" ref-type="bibr">55</xref>). To normalize read depth, all samples were randomly subsampled to 5,000 reads/sample. Shannon&#x02019;s index, Simpson&#x02019;s index, rarefaction, and Chao1 estimates were evaluated. A normalized and log<sub>10</sub>-transformed OTU abundance table was used for the &#x003b2;-diversity analysis, including principal-component analysis (PCA) and principal-coordinate analysis (PCoA) based on Bray-Curtis, UniFrac, and Jaccard distances. The taxonomy of each OTU was assigned online by RDP Classifier (RDP Naive Bayesian rRNA Classifier version 2.10) with a bootstrap cutoff of 80%.</p></sec><sec id="s3.6"><title>Coabundant network analysis.</title><p>In ecologic systems, species with similar requirements and functions would constitute an ecologic guild to adapt to the environments. Species from the same guild were shown to be coabundant. In this study, coabundant network analysis was used to find the key phylotypes associated with the improvements in glucose and lipid homeostasis. The correlations between the core OTUs (which existed in more than 20% samples) were calculated with the SparCC algorithm (bootstrap value, 100) (<xref rid="B56" ref-type="bibr">56</xref>). The 214 core OTUs were clustered into 24 coabundant groups (CAGs) by using the ward algorithm and PERMANOVA (999 permutations; <italic>P</italic> &#x0003c; 0.001) based on the SparCC correlation coefficient matrix with R version 3.1.3. The 21 CAGs with an <italic>R</italic>&#x000a0;coefficient higher than 0.4 were visualized into a network with cytoscape v3.1.1 (<ext-link ext-link-type="uri" xlink:href="http://www.cytoscape.org/">http://www.cytoscape.org/</ext-link>). The abundance of each CAG was the sum of relative abundances of the OTUs in this CAG.</p></sec><sec id="s3.7"><title>Statistical analysis.</title><p>With regard to the demographic and clinical parameter, the two-tailed <italic>t</italic>&#x000a0;test was used for paired analysis (before and after intervention). ANCOVA was used to compare treatment groups with baseline values as covariates. Missing data were handled using the last observation carried forward method. As for the gut microbiota data, Wilcoxon&#x02019;s signed-rank test was used for comparison of paired samples, and the Mann-Whitney <italic>U</italic>&#x000a0;test was used for independent samples.</p></sec><sec id="s3.8"><title>Accession number(s).</title><p>The sequence data have been uploaded to the Sequence Read Archive database under accession no. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRP126564" assigning-authority="ncbi:sra">SRP126564</ext-link>.</p></sec></sec></body><back><fn-group><fn fn-type="other"><p><bold>Citation</bold> Tong X, Xu J, Lian F, Yu X, Zhao Y, Xu L, Zhang M, Zhao X, Shen J, Wu S, Pang X, Tian J, Zhang C, Zhou Q, Wang L, Pang B, Chen F, Peng Z, Wang J, Zhen Z, Fang C, Li M, Chen L, Zhao L. 2018. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. mBio 9:e02392-17. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.02392-17">https://doi.org/10.1128/mBio.02392-17</ext-link>.</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by the National Natural Science Foundation of China (no. 81273720, 31330005, and 81401141) and the Scientific Specialized Program of Traditional Chinese Medicine of China (no. 201007004).</p><p>F.L., X.T., and L.Z. designed the study. J.X. and L.Z. drafted and revised the manuscript, with key input from J.X. and X.Y. J.X. did the statistical analyses and gut microbiome analysis. All other authors played key roles in study design, recruitment of participants, or discussion of the interpretation of data. All authors reviewed the manuscript. None of the authors reports a conflict of interest.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Aguiree</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Dahlquist</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dodd</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dunning</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hirst</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Magliano</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Soltesz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Usher-Smith</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Whiting</surname><given-names>D</given-names></name></person-group>
<year>2013</year>, <source>IDF diabetes atlas</source>, <edition>6th</edition> ed. <publisher-name>International Diabetes Federation</publisher-name>, <publisher-loc>Basel, Switzerland</publisher-loc>.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kahn</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Del Prato</surname><given-names>S</given-names></name></person-group>
<year>2014</year>
<article-title>Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future</article-title>. <source>Lancet</source>
<volume>383</volume>:<fpage>1068</fpage>&#x02013;<lpage>1083</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(13)62154-6</pub-id>.<pub-id pub-id-type="pmid">24315620</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donath</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Shoelson</surname><given-names>SE</given-names></name></person-group>
<year>2011</year>
<article-title>Type 2 diabetes as an inflammatory disease</article-title>. <source>Nat Rev Immunol</source>
<volume>11</volume>:<fpage>98</fpage>&#x02013;<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri2925</pub-id>.<pub-id pub-id-type="pmid">21233852</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group>
<year>2008</year>
<article-title>Inflammation and endoplasmic reticulum stress in obesity and diabetes</article-title>. <source>Int J Obes</source>
<volume>32</volume>(<issue>Suppl 7</issue>):<fpage>S52</fpage>&#x02013;<lpage>S54</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ijo.2008.238</pub-id>.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoelson</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Goldfine</surname><given-names>AB</given-names></name></person-group>
<year>2009</year>
<article-title>Getting away from glucose: fanning the flames of obesity-induced inflammation</article-title>. <source>Nat Med</source>
<volume>15</volume>:<fpage>373</fpage>&#x02013;<lpage>374</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm0409-373</pub-id>.<pub-id pub-id-type="pmid">19350009</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name></person-group>
<year>2013</year>
<article-title>The gut microbiota and obesity: from correlation to causality</article-title>. <source>Nat Rev Microbiol</source>
<volume>11</volume>:<fpage>639</fpage>&#x02013;<lpage>647</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3089</pub-id>.<pub-id pub-id-type="pmid">23912213</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turnbaugh</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Ley</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Mahowald</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Magrini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mardis</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<year>2006</year>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>. <source>Nature</source>
<volume>444</volume>:<fpage>1027</fpage>&#x02013;<lpage>1031</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature05414</pub-id>.<pub-id pub-id-type="pmid">17183312</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vijay-Kumar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aitken</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Cullender</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Mwangi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Srinivasan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sitaraman</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ley</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Gewirtz</surname><given-names>AT</given-names></name></person-group>
<year>2010</year>
<article-title>Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5</article-title>. <source>Science</source>
<volume>328</volume>:<fpage>228</fpage>&#x02013;<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1179721</pub-id>.<pub-id pub-id-type="pmid">20203013</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fei</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name></person-group>
<year>2013</year>
<article-title>An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice</article-title>. <source>ISME J</source>
<volume>7</volume>:<fpage>880</fpage>&#x02013;<lpage>884</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ismej.2012.153</pub-id>.<pub-id pub-id-type="pmid">23235292</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ouyang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lv</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hamaker</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Bridgewater</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Weinkove</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dore</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Nicholson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name></person-group>
<year>2015</year>
<article-title>Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children</article-title>. <source>EBioMedicine</source>
<volume>2</volume>:<fpage>968</fpage>&#x02013;<lpage>984</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ebiom.2015.07.007</pub-id>.<pub-id pub-id-type="pmid">26425705</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pruski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Krysiak</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Okopien</surname><given-names>B</given-names></name></person-group>
<year>2009</year>
<article-title>Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia</article-title>. <source>Diabetes Care</source>
<volume>32</volume>:<fpage>1421</fpage>&#x02013;<lpage>1424</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc08-2335</pub-id>.<pub-id pub-id-type="pmid">19435959</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luong</surname><given-names>DQ</given-names></name>, <name name-style="western"><surname>Oster</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ashraf</surname><given-names>AP</given-names></name></person-group>
<year>2015</year>
<article-title>Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome</article-title>. <source>J Pediatr Endocrinol Metab</source>
<volume>28</volume>:<fpage>649</fpage>&#x02013;<lpage>655</lpage>. doi:<pub-id pub-id-type="doi">10.1515/jpem-2014-0201</pub-id>.<pub-id pub-id-type="pmid">25210757</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cittadini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Napoli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Monti</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Rea</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Longobardi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Netti</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Walser</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sam&#x000e0;</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aimaretti</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Isgaard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sacc&#x000e0;</surname><given-names>L</given-names></name></person-group>
<year>2012</year>
<article-title>Metformin prevents the development of chronic heart failure in the SHHF rat model</article-title>. <source>Diabetes</source>
<volume>61</volume>:<fpage>944</fpage>&#x02013;<lpage>953</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db11-1132</pub-id>.<pub-id pub-id-type="pmid">22344560</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sabet</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Djedjos</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Radovick</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wondisford</surname><given-names>FE</given-names></name></person-group>
<year>2009</year>
<article-title>Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein</article-title>. <source>Cell</source>
<volume>137</volume>:<fpage>635</fpage>&#x02013;<lpage>646</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2009.03.016</pub-id>.<pub-id pub-id-type="pmid">19450513</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Fenyk-Melody</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ventre</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Doebber</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fujii</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Musi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hirshman</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Goodyear</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Moller</surname><given-names>DE</given-names></name></person-group>
<year>2001</year>
<article-title>Role of AMP-activated protein kinase in mechanism of metformin action</article-title>. <source>J Clin Invest</source>
<volume>108</volume>:<fpage>1167</fpage>&#x02013;<lpage>1174</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI13505</pub-id>.<pub-id pub-id-type="pmid">11602624</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonora</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cigolini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bosello</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Zancanaro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Capretti</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zavaroni</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Coscelli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Butturini</surname><given-names>U</given-names></name></person-group>
<year>1984</year>
<article-title>Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects</article-title>. <source>Curr Med Res Opin</source>
<volume>9</volume>:<fpage>47</fpage>&#x02013;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1185/03007998409109558</pub-id>.<pub-id pub-id-type="pmid">6373159</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Whon</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>JW</given-names></name></person-group>
<year>2014</year>
<article-title>An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice</article-title>. <source>Gut</source>
<volume>63</volume>:<fpage>727</fpage>&#x02013;<lpage>735</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2012-303839</pub-id>.<pub-id pub-id-type="pmid">23804561</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name></person-group>
<year>2015</year>
<article-title>Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats</article-title>. <source>Sci Rep</source>
<volume>5</volume>:<fpage>14405</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep14405</pub-id>.<pub-id pub-id-type="pmid">26396057</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forslund</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hildebrand</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Falony</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Le Chatelier</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sunagawa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Prifti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Vieira-Silva</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gudmundsdottir</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Krogh Pedersen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Arumugam</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kristiansen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Voigt</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Vestergaard</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hercog</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Costea</surname><given-names>PI</given-names></name>, <name name-style="western"><surname>Kultima</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jorgensen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Levenez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dore</surname><given-names>J</given-names></name>, <collab>MetaHIT Consortium</collab>, <name name-style="western"><surname>Nielsen</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Brunak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Raes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ehrlich</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>O</given-names></name></person-group>
<year>2015</year>
<article-title>Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota</article-title>. <source>Nature</source>
<volume>528</volume>:<fpage>262</fpage>&#x02013;<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature15766</pub-id>.<pub-id pub-id-type="pmid">26633628</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lian</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>X</given-names></name></person-group>
<year>2015</year>
<article-title>Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula</article-title>. <source>ISME J</source>
<volume>9</volume>:<fpage>552</fpage>&#x02013;<lpage>562</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ismej.2014.177</pub-id>.<pub-id pub-id-type="pmid">25279787</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name></person-group>
<year>2015</year>
<article-title>Rhizoma Anemarrhenae extract ameliorates hyperglycemia and insulin resistance via activation of AMP-activated protein kinase in diabetic rodents</article-title>. <source>J Ethnopharmacol</source>
<volume>172</volume>:<fpage>368</fpage>&#x02013;<lpage>376</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2015.05.016</pub-id>.<pub-id pub-id-type="pmid">26162543</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuangchan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sonthisombat</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Seubnukarn</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chanouan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chotchaisuwat</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sirigulsatien</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ingkaninan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Plianbangchang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Haines</surname><given-names>ST</given-names></name></person-group>
<year>2011</year>
<article-title>Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients</article-title>. <source>J Ethnopharmacol</source>
<volume>134</volume>:<fpage>422</fpage>&#x02013;<lpage>428</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2010.12.045</pub-id>.<pub-id pub-id-type="pmid">21211558</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Virdi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sivakami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shahani</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Suthar</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Banavalikar</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Biyani</surname><given-names>MK</given-names></name></person-group>
<year>2003</year>
<article-title>Antihyperglycemic effects of three extracts from Momordica charantia</article-title>. <source>J Ethnopharmacol</source>
<volume>88</volume>:<fpage>107</fpage>&#x02013;<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0378-8741(03)00184-3</pub-id>.<pub-id pub-id-type="pmid">12902059</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Huo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ning</surname><given-names>G</given-names></name></person-group>
<year>2008</year>
<article-title>Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>93</volume>:<fpage>2559</fpage>&#x02013;<lpage>2565</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2007-2404</pub-id>.<pub-id pub-id-type="pmid">18397984</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Son</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>BL</given-names></name></person-group>
<year>2013</year>
<article-title>Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial</article-title>. <source>Nutrition</source>
<volume>29</volume>:<fpage>1110</fpage>&#x02013;<lpage>1114</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nut.2013.02.015</pub-id>.<pub-id pub-id-type="pmid">23735317</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Im</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>YR</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Jo</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>YI</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>K</given-names></name></person-group>
<year>2009</year>
<article-title>Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus</article-title>. <source>Phytomedicine</source>
<volume>16</volume>:<fpage>856</fpage>&#x02013;<lpage>863</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phymed.2009.02.014</pub-id>.<pub-id pub-id-type="pmid">19303272</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>RY</given-names></name>, <name name-style="western"><surname>Halbert</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>French</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Rader</surname><given-names>DJ</given-names></name></person-group>
<year>2009</year>
<article-title>Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial</article-title>. <source>Ann Intern Med</source>
<volume>150</volume>:830&#x02013;839, <fpage>W147</fpage>&#x02013;<lpage>W149</lpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-150-12-200906160-00006</pub-id>.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verhoeven</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Van der Auwera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Van Gaal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Remmen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Apers</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stalpaert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wens</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hermans</surname><given-names>N</given-names></name></person-group>
<year>2015</year>
<article-title>Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome? A double blind, placebo controlled randomized trial</article-title>. <source>BMC Complement Altern Med</source>
<volume>15</volume>:<fpage>52</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12906-015-0576-9</pub-id>.<pub-id pub-id-type="pmid">25879228</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ning</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name></person-group>
<year>2012</year>
<article-title>Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats</article-title>. <source>PLoS One</source>
<volume>7</volume>:<elocation-id>e42529</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0042529</pub-id>.<pub-id pub-id-type="pmid">22880019</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wulffel&#x000e9;</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kooy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>de Zeeuw</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stehouwer</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Gansevoort</surname><given-names>RT</given-names></name></person-group>
<year>2004</year>
<article-title>The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review</article-title>. <source>J Intern Med</source>
<volume>256</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2796.2004.01328.x</pub-id>.<pub-id pub-id-type="pmid">15189360</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baxter</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Zackular</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>GY</given-names></name>, <name name-style="western"><surname>Schloss</surname><given-names>PD</given-names></name></person-group>
<year>2014</year>
<article-title>Structure of the gut microbiome following colonization with human feces determines colonic tumor burden</article-title>. <source>Microbiome</source>
<volume>2</volume>:<fpage>20</fpage>. doi:<pub-id pub-id-type="doi">10.1186/2049-2618-2-20</pub-id>.<pub-id pub-id-type="pmid">24967088</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saulnier</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Riehle</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mistretta</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Diaz</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mandal</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Raza</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Weidler</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Coarfa</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Milosavljevic</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petrosino</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Highlander</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gibbs</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Shulman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Versalovic</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome</article-title>. <source>Gastroenterology</source>
<volume>141</volume>:<fpage>1782</fpage>&#x02013;<lpage>1791</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2011.06.072</pub-id>.<pub-id pub-id-type="pmid">21741921</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duca</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Sakar</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lepage</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Devime</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Langelier</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dor&#x000e9;</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Covasa</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats</article-title>. <source>Diabetes</source>
<volume>63</volume>:<fpage>1624</fpage>&#x02013;<lpage>1636</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db13-1526</pub-id>.<pub-id pub-id-type="pmid">24430437</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Hold</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Barcenilla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name></person-group>
<year>2002</year>
<article-title>Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces</article-title>. <source>Int J Syst Evol Microbiol</source>
<volume>52</volume>:<fpage>1615</fpage>&#x02013;<lpage>1620</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00207713-52-5-1615</pub-id>.<pub-id pub-id-type="pmid">12361264</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Hold</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Harmsen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name></person-group>
<year>2002</year>
<article-title>Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov</article-title>. <source>Int J Syst Evol Microbiol</source>
<volume>52</volume>:<fpage>2141</fpage>&#x02013;<lpage>2146</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00207713-52-6-2141</pub-id>.<pub-id pub-id-type="pmid">12508881</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pigneur</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Watterlot</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lakhdari</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bermudez-Humaran</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Gratadoux</surname><given-names>J-J</given-names></name>, <name name-style="western"><surname>Blugeon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bridonneau</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Furet</surname><given-names>J-P</given-names></name>, <name name-style="western"><surname>Corthier</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Grangette</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vasquez</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pochart</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Trugnan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Blottiere</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Dore</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marteau</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Seksik</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Langella</surname><given-names>P</given-names></name></person-group>
<year>2008</year>
<article-title>Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>:<fpage>16731</fpage>&#x02013;<lpage>16736</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0804812105</pub-id>.<pub-id pub-id-type="pmid">18936492</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rantalainen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zuo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nicholson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name></person-group>
<year>2008</year>
<article-title>Symbiotic gut microbes modulate human metabolic phenotypes</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>:<fpage>2117</fpage>&#x02013;<lpage>2122</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0712038105</pub-id>.<pub-id pub-id-type="pmid">18252821</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#x000ed;n</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Miquel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chain</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Natividad</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Jury</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Theodorou</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bercik</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Verdu</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Langella</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Berm&#x000fa;dez-Humar&#x000e1;n</surname><given-names>LG</given-names></name></person-group>
<year>2015</year>
<article-title>Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model</article-title>. <source>BMC Microbiol</source>
<volume>15</volume>:<fpage>67</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12866-015-0400-1</pub-id>.<pub-id pub-id-type="pmid">25888448</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Schwarzer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hudcovic</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Srutkova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Stolte</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Kozakova</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Samsom</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Harmsen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>JM</given-names></name></person-group>
<year>2015</year>
<article-title>Faecalibacterium prausnitzii strain HTF-F and its extracellular polymeric matrix attenuate clinical parameters in DSS-induced colitis</article-title>. <source>PLoS One</source>
<volume>10</volume>:<elocation-id>e0123013</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0123013</pub-id>.<pub-id pub-id-type="pmid">25910186</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miquel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Leclerc</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chain</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lenoir</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Raguideau</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hudault</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bridonneau</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Northen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bowen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Berm&#x000fa;dez-Humar&#x000e1;n</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Langella</surname><given-names>P</given-names></name></person-group>
<year>2015</year>
<article-title>Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii</article-title>. <source>mBio</source>
<volume>6</volume>:<elocation-id>e00300-15</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00300-15</pub-id>.<pub-id pub-id-type="pmid">25900655</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu&#x000e9;vrain</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Maubert</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Michon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chain</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Marquant</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tailhades</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Miquel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Carlier</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Berm&#x000fa;dez-Humar&#x000e1;n</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Pigneur</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lequin</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Kharrat</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rainteau</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Aubry</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Breyner</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Afonso</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lavielle</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grill</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chassaing</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chatel</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Trugnan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Xavier</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Langella</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Seksik</surname><given-names>P</given-names></name></person-group>
<year>2016</year>
<article-title>Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn&#x02019;s disease</article-title>. <source>Gut</source>
<volume>65</volume>:<fpage>415</fpage>&#x02013;<lpage>425</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2014-307649</pub-id>.<pub-id pub-id-type="pmid">26045134</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karlsson</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Tremaroli</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nookaew</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bergstr&#x000f6;m</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Behre</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Fagerberg</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>B&#x000e4;ckhed</surname><given-names>F</given-names></name></person-group>
<year>2013</year>
<article-title>Gut metagenome in European women with normal, impaired and diabetic glucose control</article-title>. <source>Nature</source>
<volume>498</volume>:<fpage>99</fpage>&#x02013;<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12198</pub-id>.<pub-id pub-id-type="pmid">23719380</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jie</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sanchez</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Raes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Falony</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Okuda</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>M</given-names></name>, <name name-style="western"><surname>LeChatelier</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Renault</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pons</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Batto</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ehrlich</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Kristiansen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name></person-group>
<year>2012</year>
<article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>. <source>Nature</source>
<volume>490</volume>:<fpage>55</fpage>&#x02013;<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature11450</pub-id>.<pub-id pub-id-type="pmid">23023125</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jie</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>L</given-names></name></person-group>
<year>2013</year>
<article-title>Human gut microbiota changes reveal the progression of glucose intolerance</article-title>. <source>PLoS One</source>
<volume>8</volume>:<elocation-id>e71108</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0071108</pub-id>.<pub-id pub-id-type="pmid">24013136</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furet</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Tap</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Poitou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Basdevant</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bouillot</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Mariat</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Corthier</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dor&#x000e9;</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Henegar</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rizkalla</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cl&#x000e9;ment</surname><given-names>K</given-names></name></person-group>
<year>2010</year>
<article-title>Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers</article-title>. <source>Diabetes</source>
<volume>59</volume>:<fpage>3049</fpage>&#x02013;<lpage>3057</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db10-0253</pub-id>.<pub-id pub-id-type="pmid">20876719</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neyrinck</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Possemiers</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Verstraete</surname><given-names>W</given-names></name>, <name name-style="western"><surname>De Backer</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cani</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Delzenne</surname><given-names>NM</given-names></name></person-group>
<year>2012</year>
<article-title>Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice</article-title>. <source>J Nutr Biochem</source>
<volume>23</volume>:<fpage>51</fpage>&#x02013;<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio.2010.10.008</pub-id>.<pub-id pub-id-type="pmid">21411304</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>JW</given-names></name></person-group>
<year>2013</year>
<article-title>Blautia faecis sp. nov., isolated from human faeces</article-title>. <source>Int J Syst Evol Microbiol</source>
<volume>63</volume>:<fpage>599</fpage>&#x02013;<lpage>603</lpage>. doi:<pub-id pub-id-type="doi">10.1099/ijs.0.036541-0</pub-id>.<pub-id pub-id-type="pmid">22544782</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Roh</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>JW</given-names></name></person-group>
<year>2012</year>
<article-title>Blautia stercoris sp. nov., isolated from human faeces</article-title>. <source>Int J Syst Evol Microbiol</source>
<volume>62</volume>:<fpage>776</fpage>&#x02013;<lpage>779</lpage>. doi:<pub-id pub-id-type="doi">10.1099/ijs.0.031625-0</pub-id>.<pub-id pub-id-type="pmid">21571940</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Leiva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gomez-Zumaquero</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Tinahones</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Cardona</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Soriguer</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Queipo-Ortu&#x000f1;o</surname><given-names>MI</given-names></name></person-group>
<year>2013</year>
<article-title>Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study</article-title>. <source>BMC Med</source>
<volume>11</volume>:<fpage>46</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1741-7015-11-46</pub-id>.<pub-id pub-id-type="pmid">23433344</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenq</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Taur</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Devlin</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Ponce</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Goldberg</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Ahr</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Littmann</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gobourne</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Docampo</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Peled</surname><given-names>JU</given-names></name>, <name name-style="western"><surname>Arpaia</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cross</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Peets</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Lumish</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Shono</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Dudakov</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Poeck</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hanash</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Perales</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Giralt</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Pamer</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>van den Brink</surname><given-names>MR</given-names></name></person-group>
<year>2015</year>
<article-title>Intestinal Blautia is associated with reduced death from graft-versus-host disease</article-title>. <source>Biol Blood Marrow Transplant</source>
<volume>21</volume>:<fpage>1373</fpage>&#x02013;<lpage>1383</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbmt.2015.04.016</pub-id>.<pub-id pub-id-type="pmid">25977230</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Na</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>Y</given-names></name></person-group>
<year>2015</year>
<article-title>Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial</article-title>. <source>Sci Rep</source>
<volume>5</volume>:<fpage>10344</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep10344</pub-id>.<pub-id pub-id-type="pmid">25989216</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanugul</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Akao</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kakiuchi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>M</given-names></name></person-group>
<year>2005</year>
<article-title>Isolation of a human intestinal bacterium that transforms mangiferin to norathyriol and inducibility of the enzyme that cleaves a C-glucosyl bond</article-title>. <source>Biol Pharm Bull</source>
<volume>28</volume>:<fpage>1672</fpage>&#x02013;<lpage>1678</lpage>. doi:<pub-id pub-id-type="doi">10.1248/bpb.28.1672</pub-id>.<pub-id pub-id-type="pmid">16141538</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name></person-group>
<year>2016</year>
<article-title>Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium</article-title>. <source>Sci Rep</source>
<volume>6</volume>:<fpage>27572</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep27572</pub-id>.<pub-id pub-id-type="pmid">27264309</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edgar</surname><given-names>RC</given-names></name></person-group>
<year>2010</year>
<article-title>Search and clustering orders of magnitude faster than BLAST</article-title>. <source>Bioinformatics</source>
<volume>26</volume>:<fpage>2460</fpage>&#x02013;<lpage>2461</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btq461</pub-id>.<pub-id pub-id-type="pmid">20709691</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caporaso</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Kuczynski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stombaugh</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bittinger</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bushman</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Costello</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Fierer</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pe&#x000f1;a</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Goodrich</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Huttley</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Knights</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Koenig</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Ley</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Lozupone</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Muegge</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Pirrung</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Reeder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sevinsky</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Turnbaugh</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Widmann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yatsunenko</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zaneveld</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>QIIME allows analysis of high-throughput community sequencing data</article-title>. <source>Nat Methods</source>
<volume>7</volume>:<fpage>335</fpage>&#x02013;<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nmeth.f.303</pub-id>.<pub-id pub-id-type="pmid">20383131</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Alm</surname><given-names>EJ</given-names></name></person-group>
<year>2012</year>
<article-title>Inferring correlation networks from genomic survey data</article-title>. <source>PLoS Comput Biol</source>
<volume>8</volume>:<elocation-id>e1002687</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1002687</pub-id>.<pub-id pub-id-type="pmid">23028285</pub-id></mixed-citation></ref></ref-list></back></article>